This public hearing in September examined use of psychotropic medication as a chemical restraint. A chemical restraint occurs when medication is not used to treat a diagnosed mental disorder, a physical illness or a physical condition but used for the purpose of influencing a person’s behaviour. Advocates from around the country shared their observations and insights on the topic, reflecting an over-reliance on psychotropic medication to manage behaviours and inadequate oversight mechanisms and safeguards for people with disability
Source: DANA